HI HB966 | 2023 | Regular Session
Note: Carry Foward to future HB966
Status
Spectrum: Partisan Bill (Democrat 16-0)
Status: Introduced on January 25 2023 - 25% progression, died in committee
Action: 2023-01-30 - Referred to HLT, CPC, FIN, referral sheet 3
Pending: House Health Committee
Text: Latest bill text (Introduced) [HTML]
Status: Introduced on January 25 2023 - 25% progression, died in committee
Action: 2023-01-30 - Referred to HLT, CPC, FIN, referral sheet 3
Pending: House Health Committee
Text: Latest bill text (Introduced) [HTML]
Summary
Beginning on January 1, 2024, permits manufacturers of investigational drugs or biological products to make these drugs and products available to terminally ill patients under certain conditions.
Title
Relating To Access To Treatment For Terminally Ill Patients.
Sponsors
History
| Date | Chamber | Action |
|---|---|---|
| 2023-01-30 | House | Referred to HLT, CPC, FIN, referral sheet 3 |
| 2023-01-25 | House | Introduced and Pass First Reading. |
| 2023-01-23 | House | Pending introduction. |
Same As/Similar To
HB966 (Carry Over) 2023-01-30 - Referred to HLT, CPC, FIN, referral sheet 3
SB857 (Same As) 2023-02-17 - Report adopted; Passed Second Reading, as amended (SD 1) and referred to CPN/JDC.
SB857 (Same As) 2023-02-17 - Report adopted; Passed Second Reading, as amended (SD 1) and referred to CPN/JDC.
Subjects
Hawaii State Sources
| Type | Source |
|---|---|
| Summary | https://www.capitol.hawaii.gov/session/measure_indiv.aspx?billtype=HB&billnumber=966&year=2023 |
| Text | https://www.capitol.hawaii.gov/sessions/session2023/bills/HB966_.HTM |
